Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 500 of 721 entries
View as:

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05132504 Org: User:
Start: 08/31/22 End: 05/21/25 Due: 05/21/26

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00578903 Org: User:
Start: 02/28/02 End: 07/31/12 Due: 07/31/13

Dexmedetomidine in Pediatric Tonsillectomy

Phase: N/A Priority: Normal
NCT ID: NCT01057381 Org: User:
Start: 08/31/05 End: 12/31/10 Due: 12/31/11

TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03093350 Org: User:
Start: 10/10/17 End: 05/30/25 Due: 05/30/26

Traction vs. No Traction in Colonic ESD

Phase: N/A Priority: Normal
NCT ID: NCT06159634 Org: User:
Start: 12/05/23 End: 06/30/26 Due: 06/30/27

Screening for Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00848627 Org: User:
Start: 03/31/07 End: 02/29/12 Due: 02/28/13

The Role of Amylin and Glucagon in T1DM

Phase: N/A Priority: Normal
NCT ID: NCT00206258 Org: User:
Start: 07/31/02 End: 08/31/05 Due: 08/31/06

Locating Biomarkers in OCD Through Behavioral Tasks

Phase: N/A Priority: Normal
NCT ID: NCT03313622 Org: User:
Start: 03/31/25 End: 03/31/26 Due: 03/31/27

Collaborative Care for Heart Failure Patients With the Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00293852 Org: User:
Start: 02/28/06 End: 12/10/15 Due: 12/10/16

Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00656266 Org: User:
Start: 11/30/04 End: 11/30/05 Due: 11/30/06

Houston "Breathe Easy" Healthy Homes-Based Model for Multifamily Rental Communities

Phase: N/A Priority: Normal
NCT ID: NCT05345080 Org: User:
Start: 08/27/20 End: 06/30/22 Due: 06/30/23

A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device

Phase: N/A Priority: Normal
NCT ID: NCT02332759 Org: User:
Start: 07/31/14 End: 12/31/16 Due: 12/31/17

BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00717483 Org: User:
Start: 07/31/08 End: 05/31/10 Due: 05/31/11

upREACH Perinatal Home Visitation Program

Phase: N/A Priority: Normal
NCT ID: NCT06133829 Org: User:
Start: 01/22/24 End: 08/31/25 Due: 08/31/26

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00383097 Org: User:
Start: 09/30/06 End: 02/28/10 Due: 02/28/11

A Trial Of Oral Chloral Hydrate Versus Intranasal Dexmedetomidine For Sedated Abr Exams

Phase: N/A Priority: Normal
NCT ID: NCT01255904 Org: User:
Start: 08/31/11 End: 11/30/14 Due: 11/30/15

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Phase: N/A Priority: Normal
NCT ID: NCT03768310 Org: User:
Start: 06/30/22 End: 08/31/40 Due: 08/31/41

Healthy Kids-Houston: A Community Childhood Obesity Intervention Program

Phase: N/A Priority: Normal
NCT ID: NCT00994084 Org: User:
Start: 09/30/09 End: 08/31/13 Due: 08/31/14

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

Phase: N/A Priority: Normal
NCT ID: NCT00578461 Org: User:
Start: 10/31/07 End: 05/31/13 Due: 05/31/14

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Phase: N/A Priority: Normal
NCT ID: NCT00361946 Org: User:
Start: 08/31/06 End: 07/31/10 Due: 07/31/11

T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL

Phase: N/A Priority: Normal
NCT ID: NCT00709033 Org: User:
Start: 07/31/09 End: 04/30/27 Due: 04/30/28

Androxal in Male Infertility

Phase: N/A Priority: Normal
NCT ID: NCT02160704 Org: User:
Start: 09/22/14 End: 08/02/16 Due: 08/02/17

A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells

Phase: N/A Priority: Normal
NCT ID: NCT00703222 Org: User:
Start: 06/30/08 End: 05/31/25 Due: 05/31/26

Marfan Syndrome Moderate Exercise Trial II

Phase: N/A Priority: Normal
NCT ID: NCT05809323 Org: User:
Start: 09/01/23 End: 07/01/27 Due: 07/01/28

Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta

Phase: N/A Priority: Normal
NCT ID: NCT03064074 Org: User:
Start: 11/15/17 End: 07/04/22 Due: 07/04/23